MedPath

Effect of prolonged Theta burst stimulation on pain perception

Recruiting
Registration Number
CTRI/2022/05/042876
Lead Sponsor
All India Institute of Medical Sciences New Delhi
Brief Summary

This study looks into the effect of prolonging the duration of continuous and intermediate theta burst stimulation protocols on corticomotor excitability and pain perception. The limited studies so far have shown inconclusive results for prolonged continuous theta burst stimulation and prolonged intermediate theta burst protocol yet to be explored. This study will help us to conclude whether or not prolonged TBS protocols are as useful as the conventional protocols . It would take 20-30 min to assess baseline CME and QST parameters followed by 1.5 to 5 min of prolonged TBS, then CME at 5 min post stimulation. This will be followed by 45 min rest and again 20-30 min to assess final CME and QST parameters. Null Hypothesis in this study is that the prolonged TBS protocols have no effect on CME and Pain perception with the alternative hypothesis being that either prolonged continuous or prolonged intermediate or both TBS protocols have an effect on either corticomotor excitability or pain perception or both.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
36
Inclusion Criteria

right handed healthy.

Exclusion Criteria

chronic pain disorders pregnant or lactating neuropsychiatric illness on medication for neuropsychiatric illness known case of epilepsy subject with metal implants.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Corticomotor ExcitabilityBefore Stimulation | 5 mins after stimulation | 50 min after stimulation
Secondary Outcome Measures
NameTimeMethod
Tactile And Pain threshold and Tolerance for Temperature and PressureBefore Stimulation

Trial Locations

Locations (1)

All India Institute of Medical Sciences New Delhi

🇮🇳

West, DELHI, India

All India Institute of Medical Sciences New Delhi
🇮🇳West, DELHI, India
Dr Renu Bhatia
Principal investigator
8860169671
renuaiims28@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.